Key result
While clinical evaluation remains central to diagnosing acute heart failure, novel technologies such as bio-impedance and pulse wave analysis require further randomized controlled trials to establish their clinical value.
This review highlights the role of traditional and novel diagnostic technologies in improving the specificity and sensitivity of acute heart failure diagnosis to help tailor therapy to individual patient needs.
No takes yet. Share an insight, caveat, or question.
Clinical evaluation remains central in acute HF diagnosis; leaves open adoption of bio-impedance or pulse wave analysis pending RCTs.
Shoaib et al. (2013) conducted a review in Acute heart failure. While clinical evaluation remains central to diagnosing acute heart failure, novel technologies such as bio-impedance and pulse wave analysis require further randomized controlled trials to establish their clinical value.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: